Skip to content
OpenCapital
Get started

Wave Life Sciences WVE EPS (Diluted)

EPS (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
$8.26+170%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$0.56+39.8%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-$3.25-24.5%
ALN
Alnylam PharmaceuticalsALNY
$1.51+1,179%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$0.91+26.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$0.73+30.5%

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+10.1%
Enterprise value$615.92M-18.1%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's EPS (diluted)?
Wave Life Sciences (WVE) reported EPS (diluted) of -$0.13 in Q1 2026.
How has Wave Life Sciences's EPS (diluted) changed year-over-year?
Wave Life Sciences's EPS (diluted) increased by 55.2% year-over-year, from -$0.29 to -$0.13.
What is the long-term trend for Wave Life Sciences's EPS (diluted)?
Over 3 years (2021 to 2025), Wave Life Sciences's EPS (diluted) has grown at a -20.1% compound annual growth rate (CAGR), from -$2.37 to -$1.21.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.